Blackboard
   Expand   Collapse                             Search

Show details for 20142014
Show details for 20152015
Show details for 20162016
Hide details for 20172017
Show details for 0101
Show details for 0202
Show details for 0303
Show details for 0404
Show details for 0505
Show details for 0606
Show details for 0707
Show details for 0808
Show details for 0909
Show details for 1010
Show details for 1111
Hide details for 1212
12/21/201707:00 PMFDA Grants Breakthrough Therapy Designation for Avelumab in Combination with INLYTA® in Advanced Renal Cell Carcinoma Avelumab-Breakthrough-Designation-RCC-US.pdf
12/12/201710:00 AMAllan Gabor Takes Over the Leadership of Merck KGaA, Darmstadt, Germany, in ChinaPM_Gabor_US.pdf Alasdair_Jelfs.jpg Allan_Gabor.jpg
12/07/201710:00 AMMerck KGaA, Darmstadt, Germany, Receives Approval (Updated Registration) for Cladribine Tablets in Australia2017-12-07-Mavenclad-Australia-Approval-US.pdf
12/06/201710:00 AMMerck KGaA, Darmstadt, Germany, announces new head of its Semiconductor Materials businessPR_PM-I_06122017_US.pdf Wiedenbruch_23_6x6.jpg Anand_Nambiar.jpg
12/05/201702:00 PMMerck KGaA, Darmstadt, Germany Announces FDA 510(k) Clearance of Partner Genea Biomedx’s Fertility Benchtop Incubator GeriTMGERI.png MerckKGaA_PressRelease_GeriFDAClearance_5Dec2017.pdf
Show details for 20182018


   Expand   Collapse                             Search